Status:
COMPLETED
Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects Depth of Blockade
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Anesthesia
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
This study aim is to compare the effect of magnesium sulphate combined with low dose rocuronium versus standard dose rocuronium
Detailed Description
Comparing the effect of magnesium sulphate combined to low dose rocuronium versus standard dose rocuronium in cancer patients undergoing direct laryngoscopy for laryngeal tumors regarding intubating c...
Eligibility Criteria
Inclusion
- Patients with Laryngeal tumors
- ASA I-II
- Age 30-70 years
Exclusion
- Renal and or hepatic insufficiency
- Neuromuscular disease
- Large glottic and/or supra-glottic lesions with or without breathing difficulties
- Known allergy to any of the used drug
Key Trial Info
Start Date :
April 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04510337
Start Date
April 2 2018
End Date
February 20 2021
Last Update
March 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute
Cairo, Egypt, 11796